Wide Open Agriculture Ltd. · ASX:WOA
Wide Open Agriculture — Investor Presentation (July 2026)
21 slides from Wide Open Agriculture's investor presentation, July 2026
Slide 1: Commercialising the only ingredient platform built around lupins
commercialising the only ingredient platform built around lupins July - 2026 ASX: WOA
Slide 2: Disclaimer
disclaimer. DISCLAIMER This presentation has been prepared by Wide Open Agriculture Ltd (ASX: WOA) (the "Company") and was approved for release to the ASX by the Board of Directors of the Company. It does not purport to contain all the information that a prospective investor may require in connectio
Slide 3: Company snapshot
company snapshot. Our Company: Our Hero Product: Our Opportunity: we supply we created an enable F&B breakthrough entirely new manufacturers lupin-based source of protein to improve & ingredients to superior in replace the global food, nutrition, traditional beverage functionality & proteins in thei
Slide 4: Attractive valuation, considerable progress made
attractive considerable progress valuation. made. CAPITAL STRUCTURE Only listed pure-play lupin 10+ years of R&D with ✓ company globally ✓ Curtin University A$0.007 654m share price1 shares on issue2 A$4.6m A$1.27m Technology & market cap1 cash3 ✓ $35m+ invested by WOA ✓ manufacturing proven at towa
Slide 5: What are lupins?
what are lupins? Lupins are grown for sustainable After harvest 96% of global lupin Lupins are a complete plant- crop rotations production goes to animal feed2 protein and nutritional & reduce on-farm CO2 1 powerhouse › Natural nitrogen-fixing legume › Crushed into low-value feed pellets › 40% prote
Slide 6: We turn lupins into a superfood
we turn lupins into a superfood. OUR BREAKTHRO UGH building valuable IP around lupins Our patented technology splits lupin into three specialty Lupin ingredients (protein, fibre, and oil) removing off-tastes Lupins Oil and enhancing functionality. Functional Lupin Processing Improvement Drying Prote
Slide 7: Our whole seed model
our whole seed model. ✓ INITIAL SALES ★ 1ST FOCUS TRIAL SALES SECURED IN DEVELOPMENT Lup in Pro tein LP90 / BP80 Lup in O il Lup in Kernel Fibre Premium functionalised protein isolate, Specialty oil rich in oleic acid Neutral, techno-functional fibre with unique our first products to market and the
Slide 8: Why are we focused on protein first?
why are we focused on protein first? Tailwinds driving this up take D em and is exp lo ding To feed 9.8 billion people by 2050, › 30 million people on GLP-1 by 2030 in U.S.2 food demand will rise 50% - › GLP-1 users advised to prioritise high-protein diets including 70% more animal-based foods - pla
Slide 9: Our protein performs on every level
our protein performs on every level. N utritio n Functio nal › 80 – 90% high quality protein content › Outperforms soy & pea on solubility, gelation & mouthfeel 2 › Higher levels of essential amino acids versus other key plant protein1 › Neutral taste, no off-flavours, no masking agents required 2 ›
Slide 10: We sell it behind the shelf
we sell it behind the shelf. CONSUMER BRANDS WIDE OPEN AGRICULTURE they build the brands. we supply what goes inside. they own the shelf. we make their products better. › They build brand equity across retail and foodservice › A B2B ingredient company that upgrades protein channels and carry the cos
Slide 11: Every time it's included, it stays
every time it’s included, it stays. Our customers have established processes for R&D - our protein is a drop-in upgrade for many products, and an exciting cornerstone ingredient for new product development. Once we're designed in, we're very hard to remove. 1 2 3 4 5 Sam p les Fo rm ulatio n Validat
Slide 12: The hard part is already done
the hard part is already done. 10+ yrs ~A$35m + C om m ercial Reg ulatory R&D in partnership with Curtin invested by WOA to date scale proven Ap p ro val University in key markets incl. China ▲ we are here L AB SC ALE PILOT SC ALE GER M AN FAC IL IT Y C O NT R ACT MFG IN D U ST RIAL SC AL E Process
Slide 13: A strategic shift in how we make it
a strategic shift in how we make it. We are transitioning from owner-operated protein production in Germany to contract manufacturing: WHAT O UR FAC ILITY ALLO WED W H Y W E’ R E M O V I N G F O R W A R D WHAT'S N EXT FO R THE FAC ILITY › Generated initial commercial sales and › German facility has
Slide 14: Contract manufacturing is the unlock
contract manufacturing is the unlock. We are in early-stage discussions with multiple potential contract manufacturers, and developing the short list of preferred partners: Im p ro ve co st base C ash-flo w Pro tein stands Our ambition is positive gross margin, po sitive o n its o wn vs. negative in
Slide 15: How contract manufacturing works
how contract manufacturing works. Asset-light, but we keep the three things that matter: the seed sourcing, our IP, and the customer we own. 1 2 3 4 WOA SO U RC ES C O N TRAC T MFR WOA D ISTR IBU TES WOA OWN S THE We buy lupin seed at lower cost C O N VERTS C U STO M ER Finished ingredient returns t
Slide 16: Product proven, demand building
product proven. demandbuilding. The demand for our protein ingredient is real and building across an active pipeline. Immediate orders expected once manufacturing resumes DEMAND IS BUILDING PROVEN I N PRODUCTS • 8 active customers • >30 products commercialised around the world ~100 tonnes • Outstand
Slide 17: Volume & value growth drivers
volume & value growth drivers. ★ 1ST FOCUS HIGHER PRICE H I G H E R V OL UME Lup in-centric prod ucts Med ical, clinical & Prem ium pea & soy Mainstream , hybrid & perfo rmance › New products built around all three fractions, each with lupin rep lacem ent pet fo od s › One of the healthiest proteins
Slide 18: The planned path ahead
the planned path ahead. Facility idled, No material Wind-down NOW costs falling ongoing costs complete G E RMAN WIND DOWN ✓ DELIV E RABLES Sales resume at scale to current Repeat orders and NEX T Trial production period customers including China new customers Sign CM partner for protein isolate comm
Slide 19: The core team
the core team. Justin Brown Craig Swan Matthew Skinner Vincent Lauwerier Jack Guidry C HIEF EXECUTIVE O FFIC ER NO N-EXEC UTIVE D IREC TO R NO N-EXEC UTIVE D IREC TO R NON-EXECUTIVE C HAIRMAN NO N-EXEC UTIVE D IREC TO R Managing Director of Element 30 years of experience in senior With WOA since 202
Slide 20: Investment highlights
investment highlights. WHY INVEST What you're buying… First mover and years ahead. We opened the lupin protein category and lead it. A company with the world's best protein, De-risked and proven. The hard work is done - proven technology, already in products. about to unlock cost- effective manufact
Slide 21: Thank you
Thank you Craig Swan CEO craig.swan@wideopenagriculture.com.au 2/284 Oxford Street, Leederville WA 6007
Wide Open Agriculture — Investor Presentation (July 2026) on 6ix